Navigation Links
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
Date:5/17/2013

PARIS, May 17, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the pivotal study, JAKARTA, examining the selective JAK2 inhibitor SAR302503 for myelofibrosis (MF), met its primary endpoint in both dose groups. The primary endpoint assessed the proportion of patients achieving >/=35% reduction of spleen volume. Consistent with data reported in previous trials, the most common adverse events were anemia, diarrhea, nausea and vomiting. Full results will be presented at an upcoming medical congress.

MF is a rare, debilitating and life-threatening hematologic malignancy characterized by abnormal blood cell production and scarring, or fibrosis, in the bone marrow. 

"Patients with myelofibrosis in advanced stages are desperately ill and in need of treatments that will improve their outcomes. I am pleased with the results of JAKARTA and would like to thank the patients and the investigators in this trial," said Debasish Roychowdhury , M.D., Senior Vice President and Head, Sanofi Oncology. "Since Sanofi's acquisition of the molecule, SAR302503 has moved from Phase I to the completion of pivotal Phase III studies in less than three years, and now we are planning regulatory filings with authorities to make this medicine available for patients."

SAR302503 is a novel, investigational, selective JAK2 inhibitor. Sanofi Oncology is developing SAR302503 for the treatment of the three main types of myeloproliferative neoplasms: primary myelofibrosis, including those previously treated with ruxolitinib; polycythemia vera; and essential thrombocythemia.

About JAKARTA Conducted in 24 countries, the randomized, double-blind, placebo-controlled Phase III JAKARTA'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... The controversy surrounding the use of ... (procedures to remove uterine fibroids) continues, as a ... Johnson & Johnson,s Ethicon, Inc. unit, which was ... to the report published by The Wall Street ... is trying to determine what the company knew ...
(Date:5/28/2015)... 2015 Research and Markets ... the "United States Medical Adhesives Market Forecast ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , ... the United States is projected to ... Medical device manufacturers across the US are expanding ...
(Date:5/28/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces ... June 4 at 1:00 p.m. ET / 10:00 a.m. ... Internet.  Simply log onto our website listed above. If ... a replay of the webcast will be available for ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting its leadership ...
Breaking Medicine Technology:Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3
... MedPro Imaging, a premium provider ... the expansion of its operations with the opening ... in Longmont, Colo.  The 5,000-square foot facility features ... U.S. market, offering high quality computer-based transducer repair ...
... Botanic Pharmaceutical Inc. (NYSE AMEX: CBP ) ... distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ... successfully completed a feasibility study to analyze the benefits ... production operations. As a result of the study, the ...
Cached Medicine Technology:MedPro Imaging Expands Operations With Opening of Dedicated Advanced Transducer Repair Facility 2MedPro Imaging Expands Operations With Opening of Dedicated Advanced Transducer Repair Facility 3China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets 2China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets 3
(Date:5/29/2015)... 29, 2015 Healthpointe is excited to ... Therapy (JFT) at their clinics in Orange County. The ... that assists in diminishing pain for patients with osteoarthritis, ... Katz and Dr. Neil Katz of Healthpointe. Supartz is ... (also known as hyaluronic acid) a natural substance found ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report on H1 2015 pipeline ... data tables and 13 figures, spread across ...
(Date:5/29/2015)... Health DataPalooza is a national conference that ... foster the most effective and innovative ways to use ... hosted by the Health Data Consortium, which is a ... and develop the use of open healthcare data. ... narrow in on how to actually put the ideas ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 Recently, ... presented on longevity in facelift surgery before the 46th ... Puerto Vallarta, Mexico. In his presentation, Dr. Rohrich, a ... Distinguished Teaching Professor of Plastic Surgery at UT Southwestern ... to facial rejuvenation as they relate to obtaining long ...
(Date:5/29/2015)... 2015 The world of dentistry had an ... dentists as sadists who dispense pain to people unfortunate enough ... more, when it came to surgeries, people would have to ... but that's all back in the 20th Century now. Nowadays ... in the Sheepshead Bay neighborhood of Brooklyn, New ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:Dr. Rod J. Rohrich Speaks on Longevity in Facelifts and Facial Rejuvenation 2Health News:Dr. Rod J. Rohrich Speaks on Longevity in Facelifts and Facial Rejuvenation 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 4
... University psychologist clearly identifies the parts of the brain ... speech. , The study, published in the current issue ... Sciences , could help researchers better understand the speech ... person must select one word from a competing set ...
... , ... (PRWEB) December 24, 2008 -- Having decided to help support ... to find The House of Good Health in Senga Bay, Malawi. ... to manage their disease by providing financial, nutritional, and emotional support. Nick ...
... deal? Think again. , ... Phoenix, AZ (Vocus) December 23, 2008 -- ... exercise more, study results released in the December 23rd issue of Circulation ... day. Challenged by sedentary job structures most Americans fall far short of ...
... cost of prescription drugs and save money elsewhere in ... by researchers at the University of Illinois at Chicago. ... systems to provide clinical pharmacy services, $4.81 was saved ... and medication errors and other savings, says Glen Schumock, ...
... better product and so it also seems to go ... genes rearrange to allow antibodies to recognize different foreign ... recognize and attack the body,s own cells. These ... be edited into versions that won,t attack self. This ...
... Mast cells are now recognized as "granular cells of ... and as key players in the establishment of innate ... The role of mast cells in the gastrointestinal mucosa ... to actively regulate the barrier and transport properties of ...
Cached Medicine News:Health News:Rice psychologist identifies area of brain key to choosing words 2Health News:The Web Project visits The House of Good Health in Malawi 2Health News:Treadmill Desks to the Rescue: Weight Control and Activity Critical in Preventing Heart Failure 2Health News:Reduction in antibody gene rearrangement in B cells related to type 1 diabetes, lupus 2Health News:What is the effect of fluoxetine on mast cell? 2
The Model 5305 is a hand-held, portable, lightweight pulse oximeter designed for spot checking. It has a NiCad rechargeable battery....
The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery....
... memory capabilities for overnight sleep screening., ,The ... and pulse rate data, and can operate in ... ,1. The Model 130 can retain up ... patient, making the device ideally suited for treadmill ...
Medicine Products: